SARS-CoV-2/influenza A /influenza B
Jina la bidhaa
HWTS-RT148-SARS-CoV-2/influenza A /influenza B Nucleic Acid Mchanganyiko wa Utambuzi (Fluorescence PCR)
Kituo
Jina la Kituo | PCR-Mchanganyiko 1 | PCR-Mchanganyiko 2 |
Kituo cha FAM | Jeni la ORF1ab | IVA |
VIC/HEX Channel | Udhibiti wa ndani | Udhibiti wa ndani |
Kituo cha CY5 | N jeni | / |
Kituo cha ROX | E jeni | IVB |
Vigezo vya Kiufundi
Hifadhi | -18 ℃ |
Maisha ya rafu | Miezi 12 |
Aina ya Kielelezo | swabs ya nasopharyngeal na swabs ya oropharyngeal |
Lengo | SARS-CoV-2 shabaha tatu ( Orf1ab, N na E jeni)/influenza A /influenza B |
Ct | ≤38 |
CV | ≤10.0% |
LoD | SARS-CoV-2: Nakala 300/mL virusi vya mafua A: Nakala 500/mL virusi vya mafua B: Nakala 500/mL |
Umaalumu | a) Matokeo ya majaribio yalionyesha kuwa kifaa hicho kiliendana na virusi vya corona vya binadamu SARSr- CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, virusi vya kupumua vya syncytial A na B, virusi vya parainfluenza 1, 2 na 3, rhinovirusA, B na C, adenovirus 1, 2, 3, 4, 5, 7 na 55, metapneumovirus ya binadamu, enterovirus A, B, C na D, virusi vya binadamu vya cytoplasmic pulmonary, virusi vya EB, virusi vya surua Binadamu cytomegalovirus, virusi vya rotavirus, norovirus, matumbwitumbwi, virusi vya varisela zosta, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniaeber, Caspital pneumoniae, Cabakteria almaarufu, Caspital pneumoniae, Caspital pneumoniae, Bakteria ya ng'ombe ta Hapakuwa na majibu ya msalaba kati ya Pneumocystis yersini na Cryptococcus neoformans. b) Uwezo wa kuzuia mwingiliano: chagua mucin (60mg/mL), 10% (V/V) damu ya binadamu, diphenylephrine (2mg/mL), hydroxymethylzoline (2mg/mL), kloridi ya sodiamu (iliyo na kihifadhi) (20mg/mL), beclomethasone (20mg/mL), deksamethasone (20mg/mL), flunisone (20μg/mL), triamcinolone asetonidi (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), α-Interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), pramivir (1mg/mL), lopinavir (500mg/mL) ), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), ceprotene (40μg/mL) Meropenem (200mg/mL), levofloxacin (10μg/mL) na tobramycin (0.6mg/mL) .Matokeo yalionyesha kuwa vitu vinavyoingilia kati katika viwango vya juu havikuwa na mwitikio wa kuingilia kati kwa matokeo ya kugundua ya pathogens. |
Vyombo Vinavyotumika | Applied Biosystems 7500 Mifumo ya PCR ya Wakati Halisi Applied Biosystems 7500 Fast Real-Time PCR Systems SLAN ®-96P Mifumo ya PCR ya Wakati Halisi QuantStudio™ 5 Mifumo ya PCR ya Wakati Halisi LightCycler®480 Mfumo wa PCR wa Wakati Halisi LineGene 9600 Plus Mfumo wa Kugundua PCR wa Wakati Halisi MA-6000 ya Muda Halisi ya Kiasi cha Baiskeli ya Joto Mfumo wa PCR wa BioRad CFX96 wa Wakati Halisi Mfumo wa PCR wa BioRad CFX Opus 96 wa Wakati Halisi |